Related Experiment Video

Updated: Jul 15, 2026

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

[Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD]

Suguru Yamamoto1, Junichiro James Kazama

  • 1Niigata University Graduate School of Medicine and Dental Scineces, Division of Clinical Nephrology and Rheumatology, Japan.

Clinical Calcium
|May 2, 2007
PubMed

Insights

Dialysis-related amyloidosis occurs in long-term dialysis patients due to beta(2)-microglobulin (beta(2)-m) buildup. Molecules like glycosaminoglycans influence beta(2)-m amyloid fibril formation and deposition.

Area of Science:

  • Nephrology
  • Biochemistry
  • Pathology

Context:

  • Long-term dialysis patients face significant complications from amyloidosis.
  • Beta(2)-microglobulin (beta(2)-m) accumulation is a hallmark of this condition.
  • Amyloid deposits primarily affect osteoarticular tissues, leading to carpal tunnel syndrome, spondyloarthropathy, and bone cysts.

Purpose:

  • To elucidate the mechanism of beta(2)-m amyloid fibril formation in chronic kidney disease (CKD).
  • To investigate the role of specific molecules in modulating beta(2)-m amyloidogenesis.

Summary:

  • Beta(2)-microglobulin (beta(2)-m) retention in CKD patients triggers amyloid fibril formation via a nucleation-dependent polymerization process.
  • Amyloid fibrils composed mainly of beta(2)-m deposit in joints, causing significant morbidity.
  • Glycosaminoglycans and proteoglycans are identified as key modulators influencing beta(2)-m conformation, amyloid stability, and deposition.

Impact:

  • Understanding these mechanisms can inform strategies to prevent or treat dialysis-related amyloidosis.
  • Identifying key molecular players offers potential therapeutic targets for managing beta(2)-m amyloidosis.
  • This research contributes to the understanding of protein misfolding diseases in the context of renal failure.

More Related Videos

Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...